Advertisement
Advertisement
U.S. Markets open in 8 hrs 3 mins
Advertisement
Advertisement
Advertisement
Advertisement

Emmaus Life Sciences, Inc. (EMMA)

Other OTC - Other OTC Delayed Price. Currency in USD
0.4900+0.0900 (+22.50%)
At close: 03:57PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/30/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.83
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.7000
52 Week Low 30.0710
50-Day Moving Average 30.3490
200-Day Moving Average 30.3791

Share Statistics

Avg Vol (3 month) 316.86k
Avg Vol (10 day) 337.19k
Shares Outstanding 549.31M
Implied Shares Outstanding 6N/A
Float 829.85M
% Held by Insiders 167.35%
% Held by Institutions 10.00%
Shares Short (Aug 14, 2019) 441.22k
Short Ratio (Aug 14, 2019) 40.48
Short % of Float (Aug 14, 2019) 40.09%
Short % of Shares Outstanding (Aug 14, 2019) 40.09%
Shares Short (prior month Jun 27, 2019) 433.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 17, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -125.39%
Operating Margin (ttm)-58.28%

Management Effectiveness

Return on Assets (ttm)-10.87%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)16.31M
Revenue Per Share (ttm)0.33
Quarterly Revenue Growth (yoy)-33.90%
Gross Profit (ttm)17.3M
EBITDA -9.45M
Net Income Avi to Common (ttm)-20.45M
Diluted EPS (ttm)-0.1900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)982k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)27.3M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.14
Book Value Per Share (mrq)-0.31

Cash Flow Statement

Operating Cash Flow (ttm)-3.29M
Levered Free Cash Flow (ttm)5.11M
Advertisement
Advertisement